Zheng (James) Shen

Dr. Zheng (James) Shen

Nutrition, Texas A&M University, College Station, Texas, USA
orcid
PostDoc in Department of Nutrition, Texas A&M University, Co...

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2018 in Diabetes
Verified
Journal Article
Closed access
PDF file
HYHui Yan
Hui Yan
WYWangbao Yang
Wangbao Yang
FZFenghua Zhou
Fenghua Zhou
XLXiaopeng Li
Xiaopeng Li
QPQuan Pan
Quan Pan
SGShaodong Guo
Shaodong Guo
Premenopausal women exhibit enhanced insulin sensitivity and reduced incidence of type 2 diabetes (T2D) compared with age-matched men, but this advantage disappears after menopause with disrupted glucose homeostasis, in part owing to a reduction in circulating 17β-estradiol (E2). Fasting hyperglycemia is a hallmark of T2D derived largely from dysregulation of hepatic glucose production (HGP), in which Foxo1 plays a central role in the regulation of gluconeogenesis. Here, we investigated the action of E2 on glucose homeostasis in male and ovariectomized (OVX) female control and liver-specific Foxo1 knockout (L-F1KO) mice and sought to understand the mechanism by which E2 regulates gluconeogenesis via an interaction with hepatic Foxo1. In both male and OVX female control mice, subcutaneous E2 implant improved insulin sensitivity and suppressed gluconeogenesis; however, these effects of E2 were abolished in L-F1KO mice of both sexes. In our use of mouse primary hepatocytes, E2 suppressed HGP and gluconeogenesis in hepatocytes from control mice but failed in hepatocytes from L-F1KO mice, suggesting that Foxo1 is required for E2 action on the suppression of gluconeogenesis. We further demonstrated that E2 suppresses hepatic gluconeogenesis through activation of estrogen receptor (ER)α–phosphoinositide 3-kinase–Akt–Foxo1 signaling, which can be independent of insulin receptor substrates 1 and 2 (Irs1 and Irs2), revealing an important mechanism for E2 in the regulation of glucose homeostasis. These results may help explain why premenopausal women have lower incidence of T2D than age-matched men and suggest that targeting ERα can be a potential approach to modulate glucose metabolism and prevent diabetes.

1 October 2016 in Phytomedicine
Verified
Journal Article
Closed access
YZYi Mei Zheng
Yi Mei Zheng
Zheng (James) ShenZheng (James) Shen
Zheng (James) Shen
YWYan Wang
Yan Wang
ALAmy Xiaoxu Lu
Amy Xiaoxu Lu
WHWing shing Ho
Wing shing Ho

21 January 2016 in Oncology Reports
Verified
Journal Article
Closed access
YZYi Mei Zheng
Yi Mei Zheng
ALAmy Xiaoxu Lu
Amy Xiaoxu Lu
Zheng (James) ShenZheng (James) Shen
Zheng (James) Shen
AKAmy Ho Yan Kwok
Amy Ho Yan Kwok
WHWing Shing Ho
Wing Shing Ho
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications

15 March 2019 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
XLXiaopeng Li
Xiaopeng Li
YCYunmei Chen
Yunmei Chen
Zheng (James) ShenZheng (James) Shen
Zheng (James) Shen
QPQuan Pan
Quan Pan
WYWanbao Yang
Wanbao Yang
SGShaodong Guo
Shaodong Guo

6 January 2021 in Diabetes
Verified
Journal Article
Open access
PDF file
WLWang Liao
Wang Liao
WYWanbao Yang
Wanbao Yang
Zheng (James) ShenZheng (James) Shen
Zheng (James) Shen
WAWeiqi Ai
Weiqi Ai
QPQuan Pan
Quan Pan
SGShaodong Guo
Shaodong Guo
The liver is a key player for maintaining glucose homeostasis. Excessive hepatic glucose production is considered to be a key for the onset of type 2 diabetes. The primary function of heme oxygenase-1 (HO1) is to catalyze the degradation of heme into biliverdin, ferrous iron, and carbon monoxide. Previous studies have demonstrated that the degradation of heme by HO1 in the liver results in mitochondrial dysfunction and drives insulin resistance. In this study, by overexpressing HO1 in hepatocytes and mice, we showed that HO1 promotes gluconeogenesis in a Foxo1-dependent manner. Importantly, HO1 overexpression increased the generation of ferrous iron in the liver, which further activates nuclear factor-κB and phosphorylates Foxo1 at Ser273 to enhance gluconeogenesis. We further assessed the role of HO1 in insulin-resistant liver-specific knockout of IRS1 and IRS2 genes (L-DKO) mice, which exhibit upregulation of HO1 in the liver and hepatic ferrous iron overload. HO1 knockdown by shRNA or treatment of iron chelator rescued the aberrant gluconeogenesis in L-DKO mice. In addition, we found that systemic iron overload promotes gluconeogenesis by activating the hepatic protein kinase A→Foxo1 axis. Thus, our results demonstrate the role of HO1 in regulating hepatic iron status and Foxo1 to control gluconeogenesis and blood glucose.

5 April 2019 in Endocrinology
Verified
Journal Article
Closed access
PDF file
KZKebin Zhang
Kebin Zhang
XGXiaoqin Guo
Xiaoqin Guo
HYHui Yan
Hui Yan
YWYuxin Wu
Yuxin Wu
QPQuan Pan
Quan Pan
SGShaodong Guo
Shaodong Guo
The transcription factor forkhead boxO1 (FoxO1) is a key mediator in the insulin signaling pathway and controls multiple physiological functions, including hepatic glucose production (HGP) and pancreatic β-cell function. We previously demonstrated that Ser256 in human FOXO1, equivalent to Ser253 in mouse FoxO1, is a key phosphorylation site mediating the effect of insulin as a target of Akt on suppressing FOXO1 activity and expression of target genes responsible for gluconeogenesis. Here, we investigated the role of FoxO1-Ser253 phosphorylation in control of glucose hemostasis in vivo, by generating global FoxO1-S253A/A knock-in (KI) mice, in which FoxO1-Ser253 alleles were replaced with alanine (A substitution), blocking FoxO1-S253 phosphorylation. FoxO1-S253A/A mice displayed mild increases in feeding blood glucose and insulin levels, but decreases in fasting blood glucose and glucagon concentrations, as well as a reduction in the ratio of pancreatic α-cells/β-cells per islet. FoxO1-S253A/A mice exhibited a slight increase in energy expenditure, but barely altered food intake and glucose uptake among tissues. Further analyses revealed that FoxO1-S253A/A enhances FoxO1 nuclear localization and promotes the effect of glucagon on HGP. We conclude that dephosphorylation of S253 in FoxO1 may reflect a molecular basis of pancreatic plasticity during the development of insulin resistance.